Skip to main content
logo
Merck & Co., Inc. (MRK)
NYSE: MRK · Real-Time Price · USD
147.76
-0.59 (-0.40%)
At close: Aug 31, 2026, 4:00 PM EDT
148.32
+0.56 (0.38%)
After-hours: Aug 31, 2026, 7:58 PM EDT

Merck & Co. Income Statement

Millions USD. Fiscal year is Jan - Dec.
Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Revenue
16,60716,28616,40017,27615,80615,52915,62416,65716,11215,77514,63015,96215,03514,48713,83014,95914,59315,90113,52113,154
Revenue Growth (YoY)
5.07%4.88%4.97%3.72%-1.90%-1.56%6.79%4.35%7.16%8.89%5.79%6.71%3.03%-8.89%2.28%13.72%27.99%49.63%23.50%20.36%
Cost of Revenue
4,1283,8754,2953,7453,3923,3833,7073,8883,6793,4243,7954,2313,9923,8973,8433,8804,1495,3344,0873,402
Gross Profit
12,47912,41112,10513,53112,41412,14611,91712,76912,43312,35110,83511,73111,04310,5909,98711,07910,44410,5679,4349,752
Selling, General & Admin
2,7772,5662,7332,4812,4962,4042,6912,5432,5492,3182,6412,3412,5392,3632,5962,4342,4582,1812,7672,371
Research & Development
9,7423,5583,9974,0013,9953,5211,1295,8623,5003,3348,8483,3072,6223,0843,0623,5112,7762,5693,0672,338
Operating Expenses
12,5196,1246,7306,4826,4915,9253,8208,4056,0495,65211,4895,6485,1615,4475,6585,9455,2344,7505,8344,709
Operating Income
-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,6005,043
Interest Expense
-525-479-411-327-305-313-328-330-310-303-310-317-277-242-235-244-240-243-209-196
Interest & Investment Income
3535699669109146127697370731091129540157457
Currency Exchange Gain (Loss)
-37-38-99-56-78-90-50-33-60-83-162-85-62-61-17-96-86-39-95-46
Other Non Operating Income (Expenses)
594241-6991-67272444389.598122109.521918213015413542
EBT Excluding Unusual Items
-5085,8474,9756,7625,6786,0187,7984,4006,1276,429-966.55,8525,7745,0624,3915,0165,0295,6963,4764,850
Merger & Restructuring Charges
-417-9,549-1,360-390-779-205-3,643-279-177-902-401-199-10,934-1,289-107-175-258-12778-267
Gain (Loss) on Sale of Investments
242168-19537310090-155-3156143100-33-175450-58-371-284-708405683
Asset Writedown
-----------779----713-887---275-
Legal Settlements
----------0.5---572.5------
Other Unusual Items
------170-----------225-
Pretax Income
-683-3,5343,4206,7454,9995,9034,1704,0906,0065,670-2,0465,620-5,3353,6503,5133,5834,4874,8613,9095,266
Income Tax Expense
654709458958571818426929545903-82087063782549533053855485695
Earnings From Continuing Operations
-1,337-4,2432,9625,7874,4285,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2533,9494,3073,8244,571
Earnings From Discontinued Operations
-------------------62-
Net Income to Company
-1,337-4,2432,9625,7874,4285,0853,7443,1615,4614,767-1,2264,750-5,9722,8253,0183,2533,9494,3073,7624,571
Minority Interest in Earnings
231-2-1-6-1-4-6-5--5-3-4-1-5-53-4-4
Net Income
-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,7584,567
Net Income to Common
-1,335-4,2402,9635,7854,4275,0793,7433,1575,4554,762-1,2264,745-5,9752,8213,0173,2483,9444,3103,7584,567
Net Income Growth (YoY)
---20.84%83.24%-18.84%6.66%--33.47%-68.81%-46.09%--34.55%-19.72%-28.88%155.28%35.58%-55.29%
Shares Outstanding (Basic)
2,4702,4722,4882,4952,5102,5232,5372,5342,5342,5332,5332,5372,5392,5382,5362,5332,5312,5282,5272,530
Shares Outstanding (Diluted)
2,4702,4722,4882,4982,5132,5312,5372,5412,5442,5442,5332,5462,5392,5512,5482,5422,5402,5372,5352,536
Shares Change (YoY)
-1.71%-2.33%-1.93%-1.69%-1.22%-0.51%0.16%-0.20%0.20%-0.27%-0.59%0.16%-0.04%0.55%0.51%0.24%--0.16%0.20%-0.08%
EPS (Basic)
-0.54-1.721.192.321.762.011.481.252.151.88-0.481.87-2.351.111.191.281.561.701.491.81
EPS (Diluted)
-0.54-1.721.192.321.762.011.481.242.141.87-0.481.86-2.351.111.181.281.551.701.481.80
EPS Growth (YoY)
---19.28%86.99%-17.76%7.49%--33.33%-68.47%-45.31%--34.71%-20.00%-28.89%154.12%35.91%-54.78%

Additional Metrics

Fiscal Quarter
Q2 2026Q1 2026Q4 2025Q3 2025Q2 2025Q1 2025Q4 2024Q3 2024Q2 2024Q1 2024Q4 2023Q3 2023Q2 2023Q1 2023Q4 2022Q3 2022Q2 2022Q1 2022Q4 2021Q3 2021
Period Ending
Jun '26 Mar '26 Dec '25 Sep '25 Jun '25 Mar '25 Dec '24 Sep '24 Jun '24 Mar '24 Dec '23 Sep '23 Jun '23 Mar '23 Dec '22 Sep '22 Jun '22 Mar '22 Dec '21 Sep '21
Free Cash Flow
4,4772,9271,8246,8352,5291,1722,5138,5084,8462,229-7436,8152,7393323,2814,4763,1733,7773,8233,625
Free Cash Flow Per Share
1.811.180.732.741.010.460.993.351.910.88-0.292.681.080.131.291.761.251.491.511.43
Dividend Per Share
0.8500.8500.8100.8100.8100.8100.7700.7700.7700.7700.7300.7300.7300.7300.6900.6900.6900.6900.6500.650
Dividend Growth (YoY)
4.94%4.94%5.20%5.20%5.20%5.20%5.48%5.48%5.48%5.48%5.80%5.80%5.80%5.80%6.15%6.15%6.15%6.15%6.56%6.56%
Gross Margin
75.14%76.21%73.81%78.32%78.54%78.22%76.27%76.66%77.17%78.30%74.06%73.49%73.45%73.10%72.21%74.06%71.57%66.45%69.77%74.14%
Operating Margin
-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%38.34%
Profit Margin
-8.04%-26.04%18.07%33.49%28.01%32.71%23.96%18.95%33.86%30.19%-8.38%29.73%-39.74%19.47%21.82%21.71%27.03%27.11%27.79%34.72%
Free Cash Flow Margin
26.96%17.97%11.12%39.56%16.00%7.55%16.08%51.08%30.08%14.13%-5.08%42.70%18.22%2.29%23.72%29.92%21.74%23.75%28.27%27.56%
EBITDA
1,4287,6916,7938,1476,9877,2799,2115,5107,4507,6182497,0616,7636,1135,1986,0726,1016,9084,4045,780
EBITDA Margin
8.60%47.23%41.42%47.16%44.20%46.87%58.95%33.08%46.24%48.29%1.70%44.24%44.98%42.20%37.59%40.59%41.81%43.44%32.57%43.94%
D&A For EBITDA
1,4681,4041,4181,0981,0641,0581,1141,1461,0669199039788819708699388911,091804737
EBIT
-406,2875,3757,0495,9236,2218,0974,3646,3846,699-6546,0835,8825,1434,3295,1345,2105,8173,6005,043
EBIT Margin
-0.24%38.60%32.77%40.80%37.47%40.06%51.82%26.20%39.62%42.47%-4.47%38.11%39.12%35.50%31.30%34.32%35.70%36.58%26.63%38.34%
Effective Tax Rate
--13.39%14.20%11.42%13.86%10.22%22.71%9.07%15.93%-15.48%-22.60%14.09%9.21%11.99%11.40%2.17%13.20%
SEC Filings: 10-K · 10-Q